Back to today’s briefing

Story perspectives

10% of Women Face Severe Complications from Abortion Pills

5/6/2025

41 6

Center

Women Face Abortion Risks

A recent analysis from the Ethics and Public Policy Center uncovers that more than 10% of women using medication abortion face severe complications like sepsis and hemorrhaging. This alarming statistic challenges the narrative that abortion pills are safer than common pain relievers like Tylenol, raising critical questions about the FDA's approval process and the drug's safety oversight.

Right

Makary Defends Mifepristone

FDA Commissioner Marty Makary remains steadfast on mifepristone, even as alarming new data reveals nearly 11% of women experience serious complications—22 times higher than the FDA's assertions. This revelation intensifies safety concerns while activists in Missouri push back against parental consent laws, adding another layer of complexity to the already fraught abortion debate.

History

Historical Context

The recent analysis revealing that over 10% of women using medication abortion face severe complications echoes historical debates surrounding drug safety and regulatory oversight. Similar concerns arose in the 1960s with thalidomide, which caused widespread birth defects due to inadequate testing. This highlights ongoing challenges in ensuring drug safety and the implications for women's health in the abortion debate.

1 of 3

Women Face Abortion Risks

A recent analysis from the Ethics and Public Policy Center uncovers that more than 10% of women using medication abortion face severe complications like sepsis and hemorrhaging. This alarming statistic challenges the narrative that abortion pills are safer than common pain relievers like Tylenol, raising critical questions about the FDA's approval process and the drug's safety oversight.

1 / 3